General Forum, page-1602

So we have FDA approval for the pulse, it's in the process of getting it manufactured and to stores as well as the NASDAQ listing.

A sign of the times the share price is below where it was even before FDA approval, just seems too good to be accumulating here.

A look at Omron which is $16 bil AUD, the market size, and think Pulse is likely to be a disruptor as a superior product to the existing BP consumer models. From $25mil MC, with some heavy dilution still easy 100 bags+ potential. Throw in the Conneqt band... I'm stoked to have re-entered around this price and been accumulating a decent speculative parcel. I feel once NASDAQ is out of the way and we see Pulse sales, those holding should be well rewarded. Craig could have reduced the damage from the cash burn, paid himself less, but it is what it is, their tech is too good / validated to not attract funding.